Cardiac effects of in-utero exposure to antiretroviral therapy in HIV-uninfected children born to HIV-infected mothers

AIDS

Volumn 29, Issue 1, 2015, Pages 91-100

  Lipshultz, Steven E ^a,b   Williams, Paige L ^c   Zeldow, Bret ^c   Wilkinson, James D ^a   Rich, Kenneth C ^d   Van Dyke, Russell B ^e   Seage, George R ^c   Dooley, Laurie B ^f   Kaltman, Jonathan R ^g   Siberry, George K ^h   Mofenson, Lynne M ^h   Shearer, William T ⁱ   Colan, Steven D ^j   Paul, Mary ⁱ   Cooper, Norma ⁱ   Harris, Lynette ⁱ   Purswani, Murli ^k   Stuard, Emma ^k   Cintron, Anna ^k   Puga, Ana ^l   Cooley, Dia ^l   Patton, Doyle ^l   Leon, Deyana ^l   Rutstein, Richard ^m   Vincent, Carol ^m   Silverman, Nancy ^m   Yogev, Ram ⁿ   Sanders, Margaret Ann ⁿ   Malee, Kathleen ⁿ   Hunter, Scott ⁿ   Wiznia, Andrew ^o   Burey, Marlene ^o   Nozyce, Molly ^o   Borkowsky, William ^p   Deygoo, Sandra ^p   Rozelman, Helen ^p,t   Knapp, Katherine ^q   Allison, Kim ^q   Wilkins, Megan ^q   Acevedo Flores, Midnela ^r   Angeli Nieves, Lourdes ^r   Olivera, Vivian ^r   Mendez, Hermann ^s   Dennie, Ava ^s   Bewley, Susan ^s   Nachman, Sharon ^t   Oliver, Margaret ^t   Craig, Karen ^e   Sirois, Patricia ^e   Crain, Marilyn ^u   Beatty, Newana ^u   Marullo, Dan ^u   Spector, Stephen ^v   Manning, Jean ^v   Nichols, Sharon ^v   McFarland, Elizabeth ^w   Barr, Emily ^w   McEvoy, Robin ^w   Rathore, Mobeen ^x   Stowers, Kristi ^x   Usitalo, Ann ^x   Turpin, Delmyra ^d   Smith, Renee ^d   Watson, Douglas ^y   Stubbs, Latoya ^y   Belanger, Rose ^y   Dieudonne, Arry ^z   Bettica, Linda ^z   Adubato, Susan ^z   Scott, Gwendolyn ^aa   Florez, Claudia ^aa   Willen, Elizabeth ^aa   Frederick, Toinette ^ab   Davtyan, Mariam ^ab   Mejia, Maribel ^ab   Rodriguez, Zoe ^ac   Heyer, Ibet ^ac   Trifilio, Nydia Scalley ^ac   more..

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^f FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^g NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^h EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

ⁱ TEXAS CHILDREN S HOSPITAL   (United States)

^j BOSTON CHILDREN S HOSPITAL   (United States)

^k BRONX LEBANON HOSPITAL CENTER   (United States)

^l Children's Diagnostic and Treatment Center   (United States)

^m CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

ⁿ CHILDREN'S MEMORIAL HOSPITAL   (United States)

^o JACOBI MEDICAL CENTER   (United States)

^p NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^r San Juan Scientific   (United States)

^s SUNY DOWNSTATE MEDICAL CENTER   (United States)

^t STONY BROOK UNIVERSITY   (United States)

^u UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^v UNIVERSITY OF CALIFORNIA   (United States)

^w UNIVERSITY OF COLORADO   (United States)

^x UNIVERSITY OF FLORIDA   (United States)

^y UNIVERSITY OF MARYLAND   (United States)

^z UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^aa UNIVERSITY OF MIAMI   (United States)

^ab UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^ac UNIVERSITY OF PUERTO RICO   (Puerto Rico)

more..

Author keywords

Antiretroviral drugs; Cardiac; HIV; Pediatrics; Toxicity

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIVIRAL THERAPY; ARTICLE; CHILD; COHORT ANALYSIS; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; FEMALE; FIRST TRIMESTER PREGNANCY; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STRESS VELOCITY INDEX; SUBSTANCE USE; TOBACCO USE; VIRUS LOAD; ADVERSE EFFECTS; DRUG EFFECTS; EPIDEMIOLOGY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE; PRESCHOOL CHILD; PREVENTION AND CONTROL; VERTICAL TRANSMISSION; VIROLOGY;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY; FEMALE; HIV INFECTIONS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 84928011688     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000499     Document Type: Article

References (37)

1. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 33:1173-1180
2. Cooper ER, Charurat M, Mofenson L, Hanson IC, Diaz C, Hayani K, et al. Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 2002; 29: 484-494
3. Jackson JB, Musoke P, Fleming T, Guay LA, Bagenda D, Allen M, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999; 354:795-802
4. Griner R, Williams PL, Read JS, Seage GR 3rd, Crain M, Togev R, et al. In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States. AIDS Patient Care STD 2011; 25:385-394
5. Blanche S, Tardieu M, Rustin P, Slama A, Barret B, Firtion G, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999; 354:1084-1089
6. Gerschenson M, Nguyen V, Ewings EL, Ceresa A, Shaw JA, St Claire MC, et al. Mitochondrial toxicity in fetal Erythrocebus patas monkeys exposed transplacentally to zidovudine plus lamivudine. AIDS Res Hum Retroviruses 2004; 20:91-100
7. Gerschenson M, Erhart SW, Paik CY, St Claire MC, Nagashima K, Skopets B, et al. Fetal mitochondrial heart and skeletal muscle damage in Erthrocebus patas monkey exposed in utero to 3'-azido-3'-deoxythymidine. AIDS Res Hum Retroviruses 2000; 16:635-644
8. Lewis W. Mitochondrial toxicity of antiviral nucleosides used in AIDS: insights derived from toxic changes observed in tissues rich in mitochondria. In: Lipshultz SE. editor. Cardiology in AIDS New York, NY: Chapman & Hall; 1998. pp. 317-329
9. Marin-Garcia J, Goldenthal MJ, Ananthakrishnan R, Pierpont ME, Fricker FJ, Lipshultz SE, et al. Specific mitochondrial DNA deletions in idiopathic dilated cardiomyopathy. Cardiovasc Res 1996; 31:306-313
10. Marin-Garcia J, Goldenthal MJ, Ananthakrishnan R, Pierpont ME, Fricker FJ, Lipshultz SE, et al. Mitochondrial function in children with idiopathic dilated cardiomyopathy. J Inherit Metab Dis 1996; 19:309-312
11. Brogly SB, Ylitalo N, Mofenson LM, Oleske J, Van Dyke R, Crain MJ, et al. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children. AIDS 2007; 21:929-938
12. Crain MJ, Chernoff MC, Oleske JM, Brogly SB, Malee KM, Borum PR, et al. Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV. J Infect Dis 2010; 202:291-301
13. Patel K, Van Dyke RB, Mittleman MA, Colan SD, Oleske JM, Seage GR 3rd, et al. The impact of HAART on cardiomyopathy among children and adolescents perinatally infected with HIV-1. AIDS 2012; 26:2027-2037
14. Lipshultz SE, Easley KA, Orav EJ, Kaplan S, Starc TJ, Bricker JT, et al. Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med 2000; 343:759-766
15. Lipshultz SE, Shearer WT, Thompson B, Rich KC, Cheng I, Orav EJ, et al. Cardiac effects of antiretroviral therapy in HIVnegative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). J Am Coll Cardiol 2011; 57:76-85
16. Sluysmans T, Colan SD. Theoretical and empirical derivation of cardiovascular allometric relationships in children. J Appl Physiol 2005; 99:445-457
17. 2 HIV) infection study: design and methods. J Clin Epidemiol 1996; 49:1285-1294
18. Lavigne JE, Shearer WT, Thompson B, Orav EJ, Starc TJ, Colan SD, et al. Cardiovascular outcomes of pediatric seroverters perinatally exposed to HAART: design of a longitudinal clinical study. Cardiovasc Toxicol 2004; 4:187-197
19. Williams PL, Seage GR 3rd, Van Dyke RB, Siberry GK, Griner R, Tassiopoulos K, et al. A trigger-based design for evaluating the safety of in utero antiviral exposure in uninfected children of HIV-infected mothers. 2012. Am J Epidemiol 2012; 175:950-961
20. Aschengrau A, Seage GR 3rd. Essentials of epidemiology in public health, 3rd ed. Sudbury, MA: Jones and Bartlett; 2014
21. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990; l:43-46
22. Greenland S, Robins JM. Empirical-Bayes adjustments for multiple comparisons are sometimes useful. Epidemiology 1991; 2:244-251
23. Colan SD, Borow KM, Neumann A. Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load independent index of myocardial contractility. J Am Coll Cardiol 1984; 4:715-724
24. Cooper LT Jr. Myocarditis. N Engl J Med 2009; 360:1526-1538
25. Kuhl U, Schultheiss HP. Viral myocarditis: diagnosis, aetiology and management. Drugs 2009; 69:1287-1302
26. Cocker M, Friedrich MG. Cardiovascular magnetic responance of myocarditis. Curr Cardiol Rep 2010; 12:82-89
27. Wilkinson JD, Williams PL, Leister E, Zeldow B, Shearer WT, Colan SD, et al. Cardiac biomarkers in HIV-exposed uninfected children. AIDS 2013; 27:1099-1108
28. Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity [Abstract]. BM 2009; 338:a3172
29. Kuller LH, Tracy R, Belloso W, De Wit S, Drummond F, Lane HC, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med 2008; 5:e203
30. Duprez DA, Kuller LH, Tracy R, Otvos J, Cooper DA, Hoy J, et al. Lipoprotein particle subclasses, cardiovascular disease and HIV infection. Atherosclerosis 2009; 207:524-529
31. Neuhaus J, Jacobs DR Jr, Baker JV, Calmy A, Duprez D, La Rosa A, et al. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis 2010; 201:1788-1795
32. Krasemann T. QT prolongation in the newborn and maternal alcoholism. Cardiol Young 2004; 14:565-566
33. Krasemann T, Klingebiel S. Influence of chronic intrauterine exposure to alcohol on structurally normal hearts. Cardiol Young 2007; 17:185-188
34. Löser H, Pfefferkorn JR, Themann H. Alcohol in pregnancy and fetal heart damage. Klin Padiatr 1992; 204:335-339
35. Adickes ED, Mollner TJ, Makoid MC. Teratogenic effects of ethanol during hyperplastic growth in cardiac myocyte cultures. Alcohol Clin Exp Res 1993; 17:988-992
36. Wold LE, Norby FL, Hintz KK, Colligan PB, Epstein PN, Ren J. Prenatal ethanol exposure alters ventricular myocyte contractile function in the offspring of rats: influence of maternal Mg2R supplementation. Cardiovasc Toxicol 2001; 1:215-224
37. Mone SM, Gillman MW, Miller TL, Herman EH, Lipshultz SE. Effects of environmental exposures on the cardiovascular system: prenatal period through adolescence. Pediatrics 2004; 113 (Suppl 4):1058-1069.